Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma

被引:73
作者
Wright, Abigail [1 ]
Wijeratne, Aruni [1 ]
Hung, Tracy [1 ]
Gao, Wei [2 ]
Whittaker, Sean [1 ,2 ]
Morris, Steven [1 ]
Scarisbrick, Julia [1 ]
Beynon, Teresa [1 ]
机构
[1] St Thomas Hosp, London SE1 7EH, England
[2] Kings Coll London, Kings Hlth Partners, London WC2R 2LS, England
关键词
Pruritus; itch; cutaneous T-cell lymphoma; CTCL; Skindex-29; quality of life; palliative care; MYCOSIS-FUNGOIDES; INTERNATIONAL-SOCIETY; PROGNOSTIC-FACTORS; SEZARY-SYNDROME; ORGANIZATION; SURVIVAL; PROPOSAL; OUTCOMES;
D O I
10.1016/j.jpainsymman.2012.01.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Cutaneous T-cell lymphoma (CTCL), although rare, is associated with a significant symptom burden. Pruritus appears to be one of the most prominent and disturbing symptoms. Objectives. To describe the prevalence and severity of pruritus and quality of life (QOL) in patients with CTCL. Methods. Patients with CTCL able to complete two questionnaires were invited to complete a visual analogue scale for itch (VAS(itch)) and the Skindex-29. Prevalence of pruritus, mean score, and SD were estimated for the VAS(itch) and Skindex-29, and the Pearson's correlation coefficient was calculated to evaluate the relationship between severity of pruritus and QOL. Results. One hundred patients were recruited (mean [SD] age 57.9 [12.9] years, range 30-86 years). Eighty-eight percent reported pruritus in the preceding four weeks, 46% indicating that it was often or always a problem. The mean (SD) of VAS(itch) (n = 92) was 3.2 (3.2), range zero to 10. The mean (SD) total Skindex-29 score was 43.3 (27.7). More advanced disease stage was associated with poorer QOL. The Skindex-29 correlated strongly with the VAS(itch) (Pearson's correlation coefficient = 0.72, P < 0.001). Conclusion. All aspects of QOL are affected in CTCL. Pruritus is a common and troublesome symptom. A more advanced disease stage and more severe pruritus symptoms were associated with poorer QOL in this study. J Pain Symptom Manage 2013;45:114-119. (C) 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 16 条
[1]   Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal [J].
Agar, Nita Sally ;
Wedgeworth, Emma ;
Crichton, Siobhan ;
Mitchell, Tracey J. ;
Cox, Michael ;
Ferreira, Silvia ;
Robson, Alistair ;
Calonje, Eduardo ;
Stefanato, Catherine M. ;
Wain, Elizabeth Mary ;
Wilkins, Bridget ;
Fields, Paul A. ;
Dean, Alan ;
Webb, Katherine ;
Scarisbrick, Julia ;
Morris, Stephen ;
Whittaker, Sean J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4730-4739
[2]   Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases [J].
Chren, MM ;
Lasek, RJ ;
Flocke, SA ;
Zyzanski, SJ .
ARCHIVES OF DERMATOLOGY, 1997, 133 (11) :1433-1440
[3]   Significant impact of cutaneous T-cell lymphoma on patients' quality of life - Results of a 2005 National Cutaneous Lymphoma Foundation Survey [J].
Demierre, Marie-France ;
Gan, Stephanie ;
Jones, Judy ;
Miller, Donald R. .
CANCER, 2006, 107 (10) :2504-2511
[4]   Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma [J].
Demierre, MF ;
Tien, A ;
Miller, D .
ARCHIVES OF DERMATOLOGY, 2005, 141 (03) :325-330
[5]   Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma [J].
Demierre, MF ;
Kim, YH ;
Zackheim, HS .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) :1485-+
[6]  
Demierre MF, 2011, J SUPPORT ONCOL, V3, P13, DOI [DOI 10.1016/J.SUP0NC.2011.02.001, 10.1016/j.suponc.2011.02.001, DOI 10.1016/J.SUPONC.2011.02.001]
[7]   Medical progress - The pathogenesis of mycosis fungoides [J].
Girardi, M ;
Heald, PW ;
Wilson, LD .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1978-1988
[8]   Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression [J].
Kim, YH ;
Liu, HL ;
Mraz-Gernhard, S ;
Varghese, A ;
Hoppe, RT .
ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :857-866
[9]   Palliative care in patients with primary cutaneous lymphoma: Symptom burden and characteristics of hospital palliative care team input [J].
LeBon, Beata ;
Beynon, Teresa A. ;
Whittaker, Sean J. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (03) :423-424
[10]   Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) [J].
Olsen, Elise ;
Vonderheid, Eric ;
Pimpinelli, Nicola ;
Willemze, Rein ;
Kim, Youn ;
Knobler, Robert ;
Zackheim, Herschel ;
Duvic, Madeleine ;
Estrach, Teresa ;
Lamberg, Stanford ;
Wood, Gary ;
Dummer, Reinhard ;
Ranki, Annamari ;
Burg, Gunter ;
Heald, Peter ;
Pittelkow, Mark ;
Bernengo, Maria-Grazia ;
Sterry, Wolfram ;
Laroche, Liliane ;
Trautinger, Franz ;
Whittaker, Sean .
BLOOD, 2007, 110 (06) :1713-1722